In this paper, we propose a multi-scene adaptive crowd counting method based on meta-knowledge and multi-task learning. In practice, surveillance cameras are stationarily deployed in various scenes. Considering the extensibility of a surveillance system, the ideal crowd counting method should have a strong generalization capability to be deployed in unknown scenes. On the other hand, given the diversity of scenes, it should also effectively suit each scene for better performance. These two objectives are contradictory, so we propose a coarse-to-fine pipeline including meta-knowledge network and multi-task learning. Specifically, at the coarse-grained stage, we propose a generic two-stream network for all existing scenes to encode meta-knowledge especially inter-frame temporal knowledge. At the fine-grained stage, the regression of the crowd density map to the overall number of people in each scene is considered a homogeneous subtask in a multi-task framework. A robust multi-task learning algorithm is applied to effectively learn scene-specific regression parameters for existing and new scenes, which further improve the accuracy of each specific scenes. Taking advantage of multi-task learning, the proposed method can be deployed to multiple new scenes without duplicated model training. Compared with two representative methods, namely AMSNet and MAML-counting, the proposed method reduces the MAE by 10.29% and 13.48%, respectively.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104539PMC
http://dx.doi.org/10.3390/s22093320DOI Listing

Publication Analysis

Top Keywords

multi-task learning
16
crowd counting
12
meta-knowledge multi-task
8
multi-scene adaptive
8
adaptive crowd
8
counting method
8
existing scenes
8
proposed method
8
scenes
7
multi-task
5

Similar Publications

The accurate identification of protein-nucleotide binding residues is crucial for protein function annotation and drug discovery. Numerous computational methods have been proposed to predict these binding residues, achieving remarkable performance. However, due to the limited availability and high variability of nucleotides, predicting binding residues for diverse nucleotides remains a significant challenge.

View Article and Find Full Text PDF

Background: Neurodegenerative diseases are a heterogeneous group of illnesses. Differences across patients exist in the underlying biological drivers of disease. Furthermore, cross‐diagnostic disease mechanisms exist, and different pathologies often co‐occur in the brain.

View Article and Find Full Text PDF

Background: AD prevention and early interventions require tools for evaluation of people during aging for diagnosis and prognosis of AD conversion. Since AD is a complicated continuum of neurodegenerative processes, developing of such tools have been difficult because it needs longitudinal and multimodal data which are often complicated and incomplete. To address this challenge, we are developing AI4AD framework using ADNI data.

View Article and Find Full Text PDF

Background: Developing drugs for treating Alzheimer’s disease (AD) has been extremely challenging and costly due to limited knowledge on underlying biological mechanisms and therapeutic targets. Repurposing drugs or their combination has shown potential in accelerating drug development due to the reduced drug toxicity while targeting multiple pathologies.

Method: To address the challenge in AD drug development, we developed a multi‐task machine learning pipeline to integrate a comprehensive knowledge graph on biological/pharmacological interactions and multi‐level evidence on drug efficacy, to identify repurposable drugs and their combination candidates

Result: Using the drug embedding from the heterogeneous graph representation model, we ranked drug candidates based on evidence from post‐treatment transcriptomic patterns, mechanistic efficacy in preclinical models, population‐based treatment effect, and Phase 2/3 clinical trials.

View Article and Find Full Text PDF

Deep learning methods have been widely used for various glioma predictions. However, they are usually task-specific, segmentation-dependent and lack of interpretable biomarkers. How to accurately predict the glioma histological grade and molecular subtypes at the same time and provide reliable imaging biomarkers is still challenging.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!